KPIs & Operating Metrics(New)
Growth Metrics

Procter & Gamble (PG) EPS (Weighted Average and Diluted) (2016 - 2025)

Procter & Gamble (PG) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $1.78 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 5.32% to $1.78 in Q4 2025 year-over-year; TTM through Dec 2025 was $6.75, a 7.48% increase, with the full-year FY2025 number at $6.51, up 8.14% from a year prior.
  • EPS (Weighted Average and Diluted) was $1.78 for Q4 2025 at Procter & Gamble, down from $1.95 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.95 in Q3 2025 to a low of $1.13 in Q2 2021.
  • A 5-year average of $1.52 and a median of $1.53 in 2024 define the central range for EPS (Weighted Average and Diluted).
  • Biggest YoY gain for EPS (Weighted Average and Diluted) was 34.29% in 2024; the steepest drop was 12.02% in 2024.
  • Procter & Gamble's EPS (Weighted Average and Diluted) stood at $1.66 in 2021, then decreased by 4.22% to $1.59 in 2022, then dropped by 11.95% to $1.4 in 2023, then surged by 34.29% to $1.88 in 2024, then fell by 5.32% to $1.78 in 2025.
  • Per Business Quant, the three most recent readings for PG's EPS (Weighted Average and Diluted) are $1.78 (Q4 2025), $1.95 (Q3 2025), and $1.48 (Q2 2025).